Corient Private Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,230
| Closed | -$210K | – | 2528 |
|
|
2025
Q1 | $210K | Sell |
7,230
-8,151
| -53% | -$236K | ﹤0.01% | 2040 |
|
|
2024
Q4 | $571K | Buy |
15,381
+34
| +0.2% | +$1.26K | ﹤0.01% | 1545 |
|
|
2024
Q3 | $745K | Buy |
15,347
+10
| +0.1% | +$485 | ﹤0.01% | 1519 |
|
|
2024
Q2 | $613K | Sell |
15,337
-61
| -0.4% | -$2.44K | ﹤0.01% | 1535 |
|
|
2024
Q1 | $676K | Sell |
15,398
-2
| -0% | -$88 | ﹤0.01% | 1473 |
|
|
2023
Q4 | $952K | Sell |
15,400
-4,942
| -24% | -$306K | ﹤0.01% | 1303 |
|
|
2023
Q3 | $936K | Sell |
20,342
-3
| -0% | -$138 | ﹤0.01% | 1213 |
|
|
2023
Q2 | $1.17M | Buy |
20,345
+641
| +3% | +$36.8K | ﹤0.01% | 1092 |
|
|
2023
Q1 | $739K | Buy |
19,704
+7,104
| +56% | +$266K | ﹤0.01% | 1207 |
|
|
2022
Q4 | $353K | Buy |
+12,600
| New | +$353K | ﹤0.01% | 1269 |
|